OR WAIT null SECS
NEW YORK, N.Y. – June 11, 2015 – Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that PROMETRIKA, LLC, a full-service clinical research organization (CRO) supporting the biopharmaceutical and medical device industries, has increased its adoption of the Medidata Clinical Cloud® platform as part of a company-wide initiative to optimize productivity across its R&D organization. A longstanding Medidata partner, PROMETRIKA will now leverage Medidata’s innovative solution for patient-centric data capture and management (Medidata Patient Cloud®, in addition to the broad set of solutions and analytics already used through the Medidata platform, to improve operational efficiencies, resource savings and decision making.
“We’re excited to continue building our relationship with Medidata by expanding use of the Medidata platform,” said Miganush Stepanians, PhD, PROMETRIKA’s president and CEO. “At PROMETRIKA, we’re dedicated to adopting new technologies and processes that improve efficiency and promote quality for our customers. By doing away with paper-based forms and incorporating Patient Cloud into our portfolio of clinical trial applications, we’ll be able to capture better and more current patient data while reducing risk, accelerating study timelines and lowering development costs.”
A Medidata Services Partner since 2012, PROMETRIKA has implemented a number of Medidata’s cloud-based applications, including its solution for electronic data capture and management (Medidata Rave®) and randomization and supply management (Medidata Balance®). Most recently, the CRO has adopted Medidata’s electronic patient-reported outcome (ePRO) solution Patient Cloud and gained accreditation in the innovative mobile app. Available on any iOS® or Android device and automatically unified with the Medidata platform, Patient Cloud provides electronic patient questionnaire and diary functionality in a model that simplifies trial setup, eliminates the need for customized software and proprietary devices, and enhances patient engagement.
Providing over a decade of experienced, professional support across all major therapeutic areas, PROMETRIKA offers a wide range of services to its national and international life sciences customers-including clinical operations, data management, biostatistics and programming, medical writing and regulatory submissions. Based in Cambridge, Massachusetts, PROMETRIKA’s proximity to New England’s burgeoning biotechnology research environment has enabled the CRO to develop strong, collaborative relationships with companies developing some of the most innovative and promising new therapies available.
“We’re pleased to be expanding our partnership with a forward-thinking CRO like PROMETRIKA,” said Pat Bernard, Medidata’s SVP, global partner business and programs. “Medidata shares PROMETRIKA’s commitment to delivering efficient, high-quality and successful clinical development programs for life sciences companies and the patients they serve. Their recent adoption of Patient Cloud further reinforces that dedication-especially at a time when capturing the patient voice is becoming increasingly important.”